Tadashi Arao Selected Research

mitiglinide

1/2018	The Effects of Mitiglinide and Repaglinide on Postprandial Hyperglycemia in Patients Undergoing Methylprednisolone Pulse Therapy.
1/2017	Comparison Between Effectiveness of 100 mg/day Sitagliptin and a Switch to Mitiglinide Calcium Hydrate/Voglibose from 50 mg/day Sitagliptin in Patients with Type 2 Diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tadashi Arao Research Topics

Disease

13	Type 2 Diabetes Mellitus (MODY) 01/2022 - 10/2008
5	Neoplasms (Cancer) 01/2017 - 02/2006
5	Graves Disease (Basedow Disease) 01/2017 - 01/2014
3	Hyperglycemia 01/2018 - 07/2013
3	Insulin Resistance 01/2016 - 07/2012
3	Diabetes Mellitus 05/2014 - 07/2013
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2016 - 01/2015
2	Hypercalcemia (Milk Alkali Syndrome) 03/2015 - 12/2014
2	Nausea 03/2015 - 01/2012
2	Primary Hyperparathyroidism 12/2014 - 01/2013
2	Neoplasm Metastasis (Metastasis) 09/2013 - 01/2012
2	Hypocalcemia 03/2013 - 01/2013
2	Hypertension (High Blood Pressure) 01/2013 - 07/2012
2	Hypoglycemia (Reactive Hypoglycemia) 12/2012 - 02/2006
1	Dyslipidemias (Dyslipidemia) 03/2018
1	Acromegaly 01/2017
1	Immunoglobulin G4-Related Disease 01/2017
1	Pituitary Neoplasms (Pituitary Adenoma) 01/2017
1	Adenoma (Adenomas) 01/2016
1	Thyroiditis 06/2015
1	Subacute Thyroiditis (Thyroiditis, De Quervain) 06/2015
1	Fever (Fevers) 03/2015
1	Unconsciousness (Loss of Consciousness) 03/2015
1	Eosinophilia 03/2015
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 03/2015
1	Vomiting 03/2015
1	Arteriosclerosis Obliterans 12/2014
1	Osteoporosis 12/2014
1	Cerebral Infarction 12/2014
1	Albuminuria 05/2014
1	Diabetic Nephropathies (Diabetic Nephropathy) 05/2014
1	Hyperthyroidism 01/2014
1	Atherosclerosis 09/2013
1	Hypercholesterolemia 09/2013
1	Ectopic ACTH Syndrome 09/2013
1	Multiple Endocrine Neoplasia (Multiple Endocrine Adenomatosis) 09/2013
1	Thyroid Neoplasms (Thyroid Cancer) 09/2013
1	Multiple Endocrine Neoplasia Type 2b (MEN 3) 09/2013
1	Pituitary ACTH Hypersecretion 09/2013
1	Osteomalacia 03/2013
1	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 03/2013

Drug/Important Bio-Agent (IBA)

8	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 12/2012
3	alogliptinIBA 03/2018 - 07/2013
3	LipidsIBA 03/2018 - 10/2008
3	Blood Glucose (Blood Sugar)IBA 03/2018 - 01/2014
3	voglibose (Basen)IBA 01/2017 - 02/2006
3	CalciumIBA 01/2017 - 02/2006
2	oxidized low density lipoproteinIBA 03/2018 - 09/2013
2	mitiglinideIBA 01/2018 - 01/2017
2	Sitagliptin Phosphate (Januvia)FDA Link 01/2017 - 05/2014
2	Octreotide (Sandostatin)FDA LinkGeneric 01/2017 - 02/2006
2	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2016 - 03/2015
2	Rituximab (Mabthera)FDA Link 01/2016 - 01/2015
2	Thyroxine (Levothyroxine)FDA LinkGeneric 06/2015 - 03/2015
2	Glucagon-Like Peptide 1 (GLP 1)IBA 02/2015 - 05/2014
2	Parathyroid Hormone (Parathormone)IBA 12/2014 - 01/2013
2	Telmisartan (Micardis)FDA Link 01/2013 - 07/2012
1	LDL CholesterolIBA 03/2018
1	anagliptinIBA 03/2018
1	repaglinide (Prandin)FDA Link 01/2018
1	Methylprednisolone FDA LinkGeneric 01/2018
1	Dipeptidyl-Peptidase IV InhibitorsIBA 02/2017
1	VildagliptinIBA 02/2017
1	TabletsIBA 01/2017
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2017
1	Immunoglobulin G (IgG)IBA 01/2017
1	TransferasesIBA 01/2016
1	Alanine (L-Alanine)FDA Link 01/2016
1	Pharmaceutical PreparationsIBA 01/2016
1	C-PeptideIBA 01/2016
1	Prednisolone (Predate)FDA LinkGeneric 06/2015
1	Thyroglobulin FDA Link 06/2015
1	Propranolol (Inderal)FDA LinkGeneric 03/2015
1	Long-Acting Thyroid Stimulator (LATS)IBA 03/2015
1	Hydrocortisone (Cortisol)FDA LinkGeneric 03/2015
1	Methimazole (Thiamazole)FDA LinkGeneric 03/2015
1	Exenatide (Byetta)FDA Link 02/2015
1	Diphosphonates (Bisphosphonates)IBA 12/2014
1	anti-thyroid autoantibodiesIBA 12/2014
1	AlbuminsIBA 05/2014
1	Hemoglobins (Hemoglobin)IBA 05/2014
1	Rosuvastatin Calcium (Crestor)FDA Link 09/2013
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2013
1	Ezetimibe (Zetia)FDA Link 09/2013
1	Metformin (Glucophage)FDA LinkGeneric 09/2013
1	Adrenocorticotropic Hormone (ACTH)FDA Link 09/2013
1	Corticotropin-Releasing HormoneIBA 09/2013
1	Dihydrotachysterol (AT 10)IBA 09/2013
1	GlucosidasesIBA 07/2013
1	miglitol (Glyset)FDA Link 07/2013
1	Dipeptidyl-Peptidases and Tripeptidyl-PeptidasesIBA 07/2013
1	Fibroblast Growth Factor-23IBA 03/2013
1	hydroxide ionIBA 03/2013
1	Saccharated Ferric Oxide (Venofer)FDA Link 03/2013
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 03/2013

Therapy/Procedure

4	Therapeutics 01/2018 - 07/2013
2	Parathyroidectomy 12/2014 - 01/2013
1	Surgical Amputation (Amputations) 12/2014
1	Aftercare (After-Treatment) 01/2014
1	Intravenous Administration 03/2013